What is it about?
Small-cell neuroendocrine carcinomas (SCNECs) of the female genital tract are rare and aggressive tumors that are characterized by a high rate of recurrence and poor prognosis. They can arise from various sites within the female genital tract, including the cervix, endometrium, ovary, fallopian tube, vagina, and vulva. They are composed of cells with neuroendocrine features, such as the ability to produce and secrete hormones and peptides, and a high mitotic rate. Immunohistochemical staining for neuroendocrine markers, such as chromogranin A, synaptophysin, and CD56, can aid in the diagnosis of these tumors. This article provides an overview of the epidemiology, etiology, and risk factors associated with these tumors, as well as their clinical presentation, cellular characteristics, diagnosis, and finally the current treatment options for SCNECs, including surgery, chemotherapy, and radiation therapy, alone or in combination.
Featured Image
Photo by Bermix Studio on Unsplash
Why is it important?
A gold standard treatment approaches for medical radiation oncologists to treat small cell neuroendocrine tumor of female genital tract.
Perspectives
Read the Original
This page is a summary of: Small‐cell neuroendocrine carcinoma of the female genital tract: A comprehensive overview, Journal of Neuroendocrinology, April 2024, Wiley,
DOI: 10.1111/jne.13394.
You can read the full text:
Contributors
The following have contributed to this page